Case Presenter

Total ReCord, Inc.

JAN-ERIC AHLFORS '02, MS/MBA '04

Massachusetts-based company Total ReCord, Inc. specializes in the development of unique regeneration products for the nervous system. The total current global cost for treating and supporting patients suffering from injuries and neurodegeneration of the central nervous system (CNS) is staggering, totaling almost $500 billion annually worldwide.

Two of Total ReCord's products - mobilized adult stem cells (MASC) and SpheroGel™ - are showing promising results in early clinical trials in patients with chronic (long-term) spinal cord injury (SCI). Total ReCord's most unique product - Regeneration Matrix™ (RMx™) - promotes the regeneration and repatterning of injured, lesioned and degenerating CNS tissue and is expected to start FDA-approved clinical trials in SCI patients later this year.

Founder and CEO Jan-Eric Ahlfors '02, MS/MBA '04 is hopeful that following the first phases of human clinical trials, RMx™ will be placed on fast-track status for FDA approval and may soon be applied to conditions that have kept patients permanently wheelchair-bound for decades. Other products in development include the next generation RMx™ as well as Trans- Neural Implant™ and Neural Stem Cells.

An MBA graduate of WPI's Management in Technology program with degrees in biotechnology, physics and biomedical engineering, Ahlfors started New World Laboratories, Inc. at 25 and grew it into one of New England's largest biotechnology companies.

Contact information:
Jan-Eric Ahlfors, Founder and CEO
Total ReCord, Inc.
5 Biotech
Worcester MA 01605
Tel. 508-767-0100 x100
Email: eric.ahlfors@total-record.com
www.total-record.com